Skip to main content

Richard Andrew Krasuski

Professor of Medicine
Medicine, Cardiology

Selected Grants


Occluflex

Clinical TrialCo-Principal Investigator · Awarded by Occlutech US LLC · 2024 - 2029

Peer Coaching Adaptive Self-Management Interventions for Young Adults with Congenital Heart Disease (CHASM IN ACHD)

ResearchPrincipal Investigator · Awarded by Adult Congenital Heart Association · 2019 - 2023

Insmed TPIP

Clinical TrialPrincipal Investigator · Awarded by Insmed · 2021 - 2023

OVATION

Clinical TrialPrincipal Investigator · Awarded by Actelion Pharmaceutical US, Inc · 2017 - 2021

Congestive Heart Failure Device

ResearchPrincipal Investigator · Awarded by VoluMetrix, LLC · 2017 - 2018

Occluflex

Clinical TrialCo-Principal Investigator · Awarded by Occlutech US LLC · 2024 - 2029

Peer Coaching Adaptive Self-Management Interventions for Young Adults with Congenital Heart Disease (CHASM IN ACHD)

ResearchPrincipal Investigator · Awarded by Adult Congenital Heart Association · 2019 - 2023

Insmed TPIP

Clinical TrialPrincipal Investigator · Awarded by Insmed · 2021 - 2023

OVATION

Clinical TrialPrincipal Investigator · Awarded by Actelion Pharmaceutical US, Inc · 2017 - 2021

Congestive Heart Failure Device

ResearchPrincipal Investigator · Awarded by VoluMetrix, LLC · 2017 - 2018

ASO 522

Clinical TrialPrincipal Investigator · Awarded by St. Jude Medical Inc. · 2015 - 2017

External Relationships


  • Actelion Pharmaceuticals Ltd.
  • Adult Congenital Heart Association
  • Bayer Healthcare Pharmaceuticals
  • Liquidia Technologies, Inc
  • Medtronic
  • Actelion Pharmaceuticals Ltd.
  • Adult Congenital Heart Association
  • Bayer Healthcare Pharmaceuticals
  • Liquidia Technologies, Inc
  • Medtronic
  • Merck Pharma
  • Neptune Medical
  • United Therapeutics Corp.
  • W. L. Gore & Associates, Inc.

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.